OCGN
🔴 Ocugen is trading 5.2% down today on profit-taking and broader biotech sector weakness
Ocugen is trading at $1.18 (5.2% down) today as investors take profits following a recent rally sparked by FDA RMAT designation for its OCU410 gene therapy.
•...
